Comparison O
with O
alkaline I-GENE
phosphatases I-GENE
and O
5 I-GENE
- I-GENE
nucleotidase I-GENE

Pharmacologic O
aspects O
of O
neonatal O
hyperbilirubinemia O
. O

When O
CSF O
[ O
HCO3 O
-] O
is O
shown O
as O
a O
function O
of O
CSF O
PCO2 O
the O
data O
of O
K O
- O
depleted O
rats O
are O
no O
longer O
displaced O
when O
compared O
to O
controls O
but O
still O
have O
a O
significantly O
greater O
slope O
( O
1 O
. O
21 O
+/- O
0 O
. O
23 O
vs O
. O

Flurazepam O
thus O
appears O
to O
be O
an O
effective O
hypnotic O
drug O
with O
the O
optimum O
dose O
for O
use O
in O
general O
practice O
being O
15 O
mg O
at O
night O
. O

Beta O
blocking O
agents O
. O

When O
extracorporeal O
CO2 O
removal O
approximated O
CO2 O
production O
( O
VCO2 O
), O
alveolar O
ventilation O
almost O
ceased O
. O

Intravenous O
administration O
( O
25 O
mg O
/ O
kg O
) O
of O
carbonic I-GENE
anhydrase I-GENE
inhibitors O
( O
acetazolamide O
, O
methazolamide O
, O
dichlorphenamide O
, O
sulthiame O
) O
induced O
an O
early O
important O
rise O
of O
cortical O
p O
O2 O
, O
which O
is O
not O
dependent O
on O
increase O
of O
p O
O2 O
and O
p O
CO2 O
and O
decrease O
of O
pH O
in O
arterial O
blood O
. O

Teratological O
study O
of O
etoperidone O
in O
the O
rat O
and O
rabbit O
. O

Colorectal O
polyps O
should O
be O
removed O
endoscopically O
whenever O
possible O
. O

The O
variable O
HMG I-GENE
dosage O
regimen O
was O
found O
to O
offer O
no O
advantages O
when O
compared O
with O
our O
standard O
daily O
dosage O
regimen O
. O

When O
the O
CO2 O
content O
reached O
9 O
Vol O
% O
the O
animals O
became O
apathic O
and O
lost O
body O
weight O
. O

Serum I-GENE
gamma I-GENE
glutamyltransferase I-GENE
in O
the O
diagnosis O
of O
liver O
disease O
in O
cattle O
. O

By O
contrast O
, O
secretory I-GENE
HI I-GENE
antibodies I-GENE
were O
not O
demonstrated O
at O
the O
onset O
of O
illness O
in O
any O
of O
the O
patients O
, O
but O
their O
formation O
started O
early O
and O
the O
antibodies O
reached O
maximal O
levels O
about O
10 O
days O
after O
onset O
of O
illness O
. O

With O
the O
exception O
of O
virus O
assay O
and O
quantitation O
, O
these O
methods O
are O
simple O
and O
inexpensive O
enough O
to O
be O
done O
in O
typical O
shellfish O
microbiology O
laboratories O
. O

Characteristics O
of O
lipase I-GENE
activity O
. O

Takayasu O
' O
s O
disease O
: O
association O
with O
HLA I-GENE
- I-GENE
B5 I-GENE
. O

SGPT I-GENE
, O
SGOT I-GENE
, O
and O
alkaline I-GENE
phosphatase I-GENE
concentrations O
were O
essentially O
normal O
in O
all O
subjects O
. O

Gamma I-GENE
glutamyl I-GENE
transpeptidase I-GENE
( O
GGTP I-GENE
) O
activity O
in O
the O
seminal O
fluid O

Patients O
with O
Parkinson O
' O
s O
disease O
showed O
a O
relatively O
high O
incidence O
to O
psychoses O
during O
drug O
treatment O
( O
51 O
. O
47 O
%). O

Selective O
stimulation O
of O
central O
alpha I-GENE
- I-GENE
autoreceptors I-GENE
following O
treatment O
with O
alpha O
- O
methyldopa O
and O
FLA O
136 O
. O

Anti O
- O
anxiety O
action O
of O
diazepam O
after O
intra O
- O
amygdaloid O
application O
in O
the O
rat O
. O

Abstracts O
. O

Removal O
of O
thick O
, O
permanently O
altered O
mucoas O
is O
recommended O
even O
in O
the O
absence O
of O
squamous O
epithelium O
. O

An O
IgG I-GENE
monoclonal O
gammopathy O
was O
present O
in O
the O
serum O
of O
4 O
patients O
and O
Bence O
- O
Joanes O
proteinuria O
was O
found O
in O
1 O
patient O
. O

Studies O
on O
immunoglobulin I-GENE
E I-GENE
: O
the O
impact O
of O
a O
sojourn O
with O
Professor O
Dan O
H O
. O

Peroxydase I-GENE
reaction O
stains O
were O
negative O
, O
chloroacetate I-GENE
esterase I-GENE
were O
strongly O
positive O
. O

Ten O
out O
- O
patients O
with O
pustulosis O
palmaris O
et O
plantaris O
were O
examined O
with O
direct O
immunofluorescence O
( O
IF O
) O
technique O
for O
deposition O
of O
fibrinogen I-GENE
, O
fibrin I-GENE
or O
its O
degradation O
products O
( O
FR I-GENE
- I-GENE
antigen I-GENE
) O
in O
affected O
and O
unaffected O
skin O
, O
together O
with O
heparin O
- O
precipitable O
fraction O
( O
HPF O
), O
cryoglobulin I-GENE
and O
total O
plasma O
fibrinogen I-GENE
in O
the O
blood O
. O

Of O
600 O
mediastinoscopies O
carried O
out O
from O
1966 O
to O
1973 O
, O
479 O
were O
performed O
to O
assess O
the O
operability O
of O
a O
pulmonary O
carcinoma O
. O

A O
mixture O
of O
human I-GENE
albumin I-GENE
5 O
% O
and O
hydroxy O
- O
ethyl O
- O
starch O
was O
used O
as O
a O
solution O
for O
dilution O
. O

In O
the O
matched O
control O
group O
the O
acquisition O
- O
rate O
of O
both O
symptomatic O
and O
asymptomatic O
0acteriuria O
was O
over O
12 O
%, O
a O
figure O
similar O
to O
the O
percentage O
of O
women O
present O
in O
the O
practice O
population O
during O
one O
year O
with O
transient O
, O
symptomatic O
, O
and O
persistent O
A O
. O
B O
. O

Late O
complications O
of O
catheterisation O
for O
intravenous O
nutrition O
. O

Prenatal O
diagnosis O
of O
galactosaemia O
. O

Sings O
which O
are O
indicative O
of O
metaplastic O
erythropoiesis O
are O
absent O
. O

False O
positive O
amniotic I-GENE
fluid I-GENE
alpha I-GENE
fetoprotein I-GENE
levels O
resulting O
from O
contamination O
with O
fetal O
blood O
: O
results O
of O
an O
experiment O
. O

Serum O
- O
ferritin I-GENE
in O
diagnosis O
of O
haemochromatosis O
. O

In O
2 O
subjects O
the O
phytomitogen O
reactivity O
of O
the O
lymphocytes O
was O
improved O
after O
treatment O
. O

Patients O
at O
risk O
of O
hypothyroidism O
. O

Albumin I-GENE
and O
cyclic O
AMP O
levels O
in O
peritoneal O
fluids O
in O
the O
child O

Preface O
. O

Thirty O
- O
five O
strains O
of O
Legionnaires O
' O
disease O
bacteria O
were O
shown O
to O
belong O
in O
four O
distinct O
serologic O
groups O
on O
the O
basis O
of O
findings O
obtained O
with O
direct O
fluorescent O
antibody O
testing O
. O

On O
the O
other O
hand O
factor I-GENE
IX I-GENE
activity O
is O
decreased O
in O
coumarin O
treatment O
with O
factor I-GENE
IX I-GENE
antigen O
remaining O
normal O
. O

The O
concentration O
of O
alpha I-GENE
2 I-GENE
- I-GENE
macroglobulin I-GENE
, O
alpha I-GENE
1 I-GENE
- I-GENE
antitrypsin I-GENE
, O
plasminogen I-GENE
, O
C3 I-GENE
- I-GENE
complement I-GENE
, O
fibrinogen I-GENE
degradation I-GENE
products I-GENE
( O
FDP I-GENE
) O
and O
fibrinolytic O
activity O
, O
were O
studied O
in O
the O
aqueous O
humour O
and O
serum O
from O
nine O
patients O
with O
Fuchs O
' O
endothelial O
dystrophy O
, O
17 O
patients O
with O
uncomplicated O
senile O
cataract O
and O
in O
the O
secondary O
aqueous O
from O
six O
cataract O
patients O
. O

Only O
17 O
% O
of O
all O
patients O
admitted O
it O
at O
all O
times O
. O

Prazosin O
alone O
was O
effective O
in O
volume O
responsive O
patients O
at O
a O
dose O
of O
5 O
+/- O
1 O
. O
0 O
mg O
daily O
. O

T4 O
and O
FT4I O
followed O
parallel O
courses O
in O
both O
groups O
; O
during O
the O
first O
45 O
days O
, O
however O
, O
the O
values O
were O
significantly O
lower O
in O
premature O
infants O
under O
34 O
weeks O
' O
EGA O
than O
in O
term O
infants O
( O
P O
less O
than O
0 O
. O
001 O
). O

A O
three O
- O
phased O
analysis O
of O
treatment O
plans O
for O
45 O
patients O
was O
undertaken O
. O

Aspirin O
intolerance O
: O
unaltered O
susceptibility O
of O
platelet I-GENE
cyclo I-GENE
- I-GENE
oxygenase I-GENE
to O
inhibition O
by O
aspirin O
in O
vitro O
. O

These O
results O
indicate O
that O
cynomolgus O
monkeys O
are O
either O
less O
sensitive O
or O
respond O
differently O
than O
rhesus O
monkeys O
to O
some O
of O
the O
pharmacological O
effects O
of O
norcocaine O
. O

59 O
cases O
of O
surgically O
resectable O
cancers O
( O
T1 O
, O
T2 O
, O
T3 O
, O
N0 O
, O
N1 O
) O
had O
a O
minimum O
followup O
of O
two O
years O
( O
average O
4 O
years O
+/- O
3 O
months O
). O

The O
effect O
of O
CBZ O
and O
DPH O
can O
be O
explained O
by O
interference O
with O
thyroid O
hormone O
binding O
to O
TBG I-GENE
combined O
with O
enzyme O
- O
induced O
increased O
metabolic O
clearance O
rate O
of O
thyroid O
hormones O
without O
homeostatic O
maintenance O
of O
premedication O
levels O
of O
FT4 O
and O
FT3 O
. O

The O
present O
research O
evaluated O
the O
possibility O
that O
polyethylene O
glycol O
400 O
( O
PEG O
400 O
) O
might O
be O
efficacious O
, O
toxic O
, O
or O
both O
. O

According O
to O
their O
functional O
properties O
the O
latter O
neurons O
were O
subdivided O
into O
: O
( O
a O
) O
neurons O
responding O
to O
stimuli O
near O
the O
eyes O
; O
( O
b O
) O
neurons O
triggered O
by O
complex O
visual O
stimuli O
; O
( O
c O
) O
neurons O
inhibited O
by O
visual O
stimuli O
. O

Pentobarbital O
( O
1 O
, O
3 O
, O
10 O
, O
and O
17 O
. O
5 O
mg O
/ O
kg O
) O
was O
also O
tested O
in O
combination O
with O
rate O
- O
decreasing O
doses O
of O
normeperidine O
( O
17 O
. O
5 O
mg O
/ O
kg O
), O
anileridine O
( O
10 O
mg O
/ O
kg O
), O
alphaprodine O
( O
10 O
mg O
/ O
kg O
), O
and O
fentanyl O
( O
0 O
. O
3 O
mg O
/ O
kg O
). O

Pb O
foil O
( O
0 O
. O
55 O
gcm O
- O
2 O
) O
provided O
the O
best O
overall O
improvement O
. O

An O
anatomical O
and O
histochemical O
study O
has O
been O
undertaken O
and O
as O
a O
result O
emphasis O
is O
given O
to O
recent O
hypotheses O
that O
suggest O
there O
are O
similarities O
with O
Type O
IV O
glycogen O
storage O
disease O
( O
Andersen O
' O
s O
disease O
) O
which O
, O
although O
clinically O
distinct O
, O
has O
the O
same O
enzyme O
defect O
. O

All O
groups O
were O
tested O
in O
a O
Hebb O
- O
Williams O
maze O
at O
100 O
approximately O
10 O
days O
of O
age O
. O

Erythromycin O
and O
clindamycin O
resistance O
in O
Corynebacterium O
diphtheriae O
from O
skin O
lesions O
. O

Imposed O
angular O
displacements O
of O
monkey O
' O
s O
wrist O
produce O
three O
major O
peaks O
of O
activity O
( O
terms O
M1 O
, O
M2 O
, O
and O
M3 O
peaks O
) O
in O
the O
averaged O
gross O
EMG O
activity O
ot O
the O
stretched O
muscles O
. O

Hemolytic O
disease O
of O
African O
newborn O
. O

In O
this O
animal O
, O
infected O
with O
what O
was O
judged O
previously O
to O
be O
the O
less O
virulent O
of O
the O
two O
T O
. O
cruzi O
stocks O
used O
(' O
strain O
7 O
'), O
there O
was O
severe O
myocarditis O
, O
with O
myofibre O
degeneration O
, O
and O
lesions O
of O
the O
oesophagus O
. O

The O
majority O
of O
MRF O
units O
were O
behaviorally O
incongruent O
; O
in O
the O
most O
frequently O
observed O
case O
, O
their O
activity O
failed O
to O
change O
reliably O
when O
behavior O
habituated O
. O

Variability O
within O
Down O
' O
s O
syndrome O
( O
trisomy O
- O
21 O
): O
empirically O
observed O
sex O
differences O
in O
IQs O
. O

VII O
. O

Several O
demographic O
indices O
of O
isolated O
populations O
in O
Uzbekistan O

2 O
.-- O
concepts O
of O
higher O
nervous O
function O
in O
the O
USSR O
. O

The O
maintenance O
of O
increased O
myocardial O
capillary O
density O
required O
a O
similar O
amount O
of O
exercise O
, O
and O
at O
least O
1 O
h O
of O
exercise O
once O
a O
week O
was O
necessary O
to O
maintain O
the O
enlargement O
of O
ECA O
. O
20 O

These O
observations O
have O
led O
us O
to O
conclude O
that O
an O
elevated O
VIII O
- O
ratio O
is O
a O
very O
sensitive O
indicator O
of O
intravascular O
coagulation O
. O

Eight O
hours O
after O
the O
administration O
of O
colchicine O
, O
the O
serum I-GENE
ceruloplasmin I-GENE
level O
began O
to O
rise O
again O
in O
female O
rats O
, O
but O
not O
in O
male O
rats O
. O

Radioimmunoassays O
of O
pregnenolone O
, O
progesterone O
, O
dehydroepiandrosterone O
( O
DHA O
) O
16 O
alpha O
- O
hydroxy O
- O
DHA O
, O
estriol O
, O
and O
cortisol O
were O
performed O
on O
a O
total O
of O
0 O
; O
1 O
ml O
; O
of O
fetal O
plasma O
, O
collected O
during O
the O
course O
of O
normal O
vaginal O
delivery O
. O

In O
only O
two O
patients O
were O
we O
able O
to O
demonstrate O
changes O
suggestive O
of O
pulmonary O
metastases O
any O
earlier O
with O
a O
99mTc O
- O
EHDP O
scan O
than O
with O
chest O
radiographs O
and O
one O
of O
these O
resolved O
spontaneously O
. O

The O
majority O
of O
tumors O
occurred O
in O
the O
nasal O
cavities O
, O
although O
significant O
incidences O
were O
also O
found O
in O
the O
larynx O
, O
trachea O
and O
stem O
bronchi O
. O

Prediction O
of O
the O
times O
of O
sandfly O
development O

Native O
human I-GENE
fibrinogen I-GENE
was O
brought O
to O
coagulation O
by O
adding O
thrombin I-GENE
. O

No O
post O
- O
operative O
haemorrhages O
from O
the O
prostheses O
were O
observed O
. O

The O
Southern O
technique O
allowed O
a O
further O
localization O
of O
the O
region O
of O
most O
extensive O
transcription O
to O
a O
1 O
. O
8 O
kb O
HindIII I-GENE
- O
EcoRI I-GENE
fragment O
. O

Accepting O
arbitrarily O
chosen O
limits O
of O
maximized O
errors O
of O
+/- O
10 O
%, O
it O
could O
be O
shown O
that O
the O
system O
did O
not O
work O
acceptably O
when O
the O
mean O
carbon O
dioxide O
concentration O
was O
below O
1 O
. O
5 O
vol O
.% O
within O
the O
fresh O
gas O
flow O
rates O
( O
2 O
. O
2 O
-- O
7 O
. O
7 O
1 O
min O
- O
1 O
) O
and O
the O
range O
of O
minute O
ventilation O
( O
4 O
-- O
10 O
1 O
min O
- O
1 O
) O
employed O
. O

SV O
increased O
less O
in O
SHR O
, O
mainly O
reflecting O
the O
reduced O
diastolic O
compliance O
of O
the O
hypertrophied O
SHR O
left O
ventricle O
and O
the O
consequent O
rightward O
shift O
of O
its O
Frank O
- O
Starling O
curve O
. O

The O
carcass O
of O
a O
great O
horned O
owl O
( O
Bubo O
virginianus O
), O
which O
had O
been O
found O
moribund O
in O
southern O
Ontario O
, O
was O
presented O
for O
necropsy O
. O

The O
inner O
ears O
were O
exposed O
by O
microdissection O
, O
and O
the O
vestibular O
sensory O
regions O
were O
either O
sectioned O
and O
studied O
with O
light O
or O
electron O
microscopy O
, O
or O
prepared O
and O
studied O
with O
the O
surface O
specimen O
technique O
. O

Patulin O
is O
extracted O
from O
apple O
butter O
samples O
with O
ethyl O
acetate O
and O
the O
extract O
is O
cleaned O
up O
on O
a O
silica O
gel O
column O
, O
using O
benzene O
- O
ethyl O
acetate O
( O
75 O
+ O
25 O
) O
as O
the O
eluant O
. O

Steroid O
glucuronides O
in O
amniotic O
fluid O
at O
term O
. O

The O
matrix O
surrounding O
the O
clusters O
either O
showed O
a O
normal O
morphology O
or O
a O
homogeneous O
appearance O
, O
within O
which O
faint O
cross O
striations O
but O
no O
distinctly O
fibrillar O
outlines O
could O
be O
identified O
. O

Riboflavin O
did O
not O
affect O
the O
percentage O
of O
aflatoxin O
- O
treated O
animals O
with O
abnormal O
urinary O
excretion O
patterns O
, O
but O
did O
increase O
the O
magnitude O
of O
the O
disturbances O
in O
elimination O
of O
kynurenic O
and O
xanthurenic O
acids O
. O

Polyglactin O
910 O
suture O
absorption O
and O
the O
role O
of O
cellular O
enzymes O
. O

The O
incidence O
of O
DNCB O
reactions O
was O
78 O
per O
cent O
for O
Stage O
I O
and O
II O
cancers O
( O
37 O
patinets O
), O
73 O
per O
cent O
for O
resectable O
Stage O
III O
cancer O
( O
22 O
patients O
), O
and O
66 O
per O
cent O
in O
patients O
with O
unresectable O
or O
inoperable O
Stage O
III O
cancer O
. O

Studies O
of O
lipoproteins O
should O
, O
however O
, O
be O
made O
in O
children O
from O
families O
known O
to O
have O
FH O
or O
early O
coronary O
heart O
disease O
. O

Sixteen O
other O
normal O
subjects O
with O
2 O
g O
of O
Metyrapone O
are O
best O
responses O
. O

EEG O
theta O
waves O
and O
psychological O
phenomena O
: O
a O
review O
and O
analysis O
. O

REM O
dream O
content O
was O
scored O
for O
categories O
suggesting O
the O
predominant O
influence O
of O
the O
left O
hemisphere O
, O
e O
. O
g O
., O
good O
ego O
functioning O
, O
verbalization O
, O
or O
the O
right O
hemisphere O
, O
e O
. O
g O
., O
music O
, O
spatial O
salience O
, O
bizarreness O
. O

Innervation O
of O
the O
ventral O
diaphragm O
of O
the O
locust O
( O
Locusta O
migratoria O
). O

Ectopic O
ACTH I-GENE
syndrome O
and O
medullary O
thyroid O
carcinoma O
. O

A O
striking O
finding O
in O
all O
of O
the O
studies O
was O
a O
positive O
correlation O
between O
PI O
ACTH I-GENE
and O
MSH I-GENE
contents O
. O

Chronic O
hypophosphatemia O
is O
the O
most O
common O
type O
of O
" O
resistant O
" O
rickets O
. O

There O
was O
no O
correlation O
between O
serum I-GENE
LH I-GENE
and O
chronological O
or O
bone O
age O
in O
this O
age O
group O
, O
which O
suggests O
that O
the O
correlation O
found O
is O
not O
due O
to O
age O
- O
related O
parallel O
phenomena O
. O

Molecular O
neurochemistry O
of O
addictive O
drugs O
. O

Efforts O
were O
made O
to O
determine O
the O
amount O
of O
time O
required O
for O
kidney O
lesions O
to O
develop O
and O
, O
if O
possible O
, O
to O
delineate O
the O
potential O
site O
of O
action O
of O
PBB O
. O

Effect O
of O
succimer O
on O
the O
intensity O
of O
tricarboxylic I-GENE
acid I-GENE
dehydrogenase I-GENE
reactions O
in O
the O
brain O
of O
rats O
poisoned O
with O
mercuric O
chloride O

Distribution O
and O
correlations O
of O
serum O
uric O
- O
acid O
in O
two O
French O
adult O
populations O
: O
13 O
, O
885 O
men O
and O
6 O
, O
861 O
women O

The O
incidence O
of O
hepatitis I-GENE
B I-GENE
antigen I-GENE
following O
transfusion O
was O
about O
2 O
. O
8 O
per O
cent O
. O

Technetium O
- O
99m O
stannous O
pyrophosphate O
myocardial O
scintigrams O
were O
obtained O
in O
138 O
clinically O
stable O
patients O
32 O
. O
7 O
+/- O
47 O
. O
3 O
weeks O
( O
range O
6 O
to O
260 O
) O
after O
acute O
myocardial O
infarction O
. O

A O
similar O
phenomenon O
has O
been O
reported O
in O
a O
few O
humans O
. O

The O
decline O
in O
the O
activity O
of O
cytochrome I-GENE
oxidase I-GENE
, O
peroxidase I-GENE
and O
in O
the O
lipid O
content O
of O
peripheral O
neutrophils O
was O
followed O
by O
a O
decrease O
in O
the O
phagocytic O
activity O
. O

Treatment O
of O
2 O
patients O
with O
pseudohypoparathyroidism O
type O
I O
with O
vitamin O
- O
D O
- O
3 O
and O
1 O
alpha O
- O
Hydroxycholecalciferol O
consecutively O
resulted O
in O
a O
nonuniform O
response O
with O
regard O
to O
the O
normalisation O
of O
serum O
- O
calcium O
. O

Workers O
with O
" O
sensitivity O
" O
to O
toluene O
diisocyanate O
( O
TDI O
) O
studied O
in O
depth O
in O
an O
attempt O
to O
determine O
mechanisms O
of O
bronchial O
hyperreactivity O
. O

Total O
VO2 O
was O
decreased O
in O
both O
groups O
during O
severe O
hypoxia O
but O
limb O
VO2 O
was O
maintained O
in O
the O
beta O
- O
block O
group O
. O
beta O
- O
Block O
prevented O
the O
fall O
in O
total O
and O
limb O
peripheral O
resistance O
seen O
in O
severe O
hypoxia O
but O
did O
not O
alter O
the O
consistently O
more O
efficient O
utilization O
of O
total O
O2 O
delivery O
shown O
by O
the O
limb O
in O
comparison O
to O
the O
whole O
body O
by O
higher O
O2 O
extraction O
ratios O
and O
lower O
venous O
O2 O
pressure O
. O
beta I-GENE
- I-GENE
Vasodilator I-GENE
receptors I-GENE
evidently O
played O
an O
active O
part O
in O
the O
vasodilatation O
seen O
during O
severe O
hypoxia O
. O

Phenobarbital O
- O
induced O
alterations O
in O
the O
metabolism O
of O
[ O
3H O
] O
vitamin O
D3 O
by O
the O
perfused O
rachitic O
rat O
liver O
in O
vitro O
. O

Modulation O
of O
25 I-GENE
- I-GENE
hydroxyvitamin I-GENE
D3 I-GENE
- I-GENE
24 I-GENE
- I-GENE
hydroxylase I-GENE
by O
aminophylline O
: O
a O
cytochrome I-GENE
P I-GENE
- I-GENE
450 I-GENE
monooxygenase I-GENE
system O
. O

In O
both O
these O
respects O
, O
however O
, O
the O
DBP I-GENE
mRNA I-GENE
resembles O
the O
late O
messengers O
of O
SV40 O
and O
polyoma O
viruses O
. O

Effect O
of O
corticosteroid O
- O
containing O
antirheumatic O
combination O
drugs O
on O
endogenous O
ACTH I-GENE
and O
cortisol O
production O
. O

Serum I-GENE
ACTH I-GENE
did O
not O
respond O
to O
insulin I-GENE
and O
metyrapone O
. O

Anatomy O
of O
the O
RNA O
and O
gene O
products O
of O
MC29 O
and O
MH2 O
, O
two O
defective O
avian O
tumor O
viruses O
causing O
acute O
leukemia O
and O
carcinoma O
: O
evidence O
for O
a O
new O
class O
of O
transforming O
genes O
. O

Bertioga O
( O
Guama O
group O
) O
and O
Anhembi O
( O
Bunyamwera O
group O
), O
two O
new O
arboviruses O
isolated O
in O
Sao O
Paulo O
, O
Brazil O
. O

Gamma I-GENE
glutamyl I-GENE
transpeptidase I-GENE
activity O
was O
increased O
up O
to O
15 O
times O
above O
the O
upper O
normal O
limit O
in O
children O
, O
who O
received O
aminopyrine O
for O
two O
weeks O
or O
longer O
. O

XXI O
. O

A O
gas O
- O
liquid O
chromatographic O
method O
for O
the O
determination O
of O
p O
- O
chlorophenoxyisobutyric O
( O
CPIB O
) O
acid O
in O
blood O
plasma O
is O
described O
. O

Dopamine I-GENE
receptor I-GENE
blockade O
and O
the O
neuroleptics O
, O
a O
crystallographic O
study O
. O

V O
. O

A O
rapid O
fluorimetric O
procedure O
for O
the O
determination O
of O
the O
fungicide O
5 O
- O
fluorocytosine O
in O
serum O
is O
described O
. O

The O
' O
field O
of O
stress O
' O
of O
the O
supervisory O
nurse O

How O
do O
graduates O
of O
different O
types O
of O
programs O
perform O
on O
state O
boards O
? O

Similarly O
, O
maternal I-GENE
serum I-GENE
somatomedin I-GENE
A I-GENE
was O
significantly O
reduced O
in O
rats O
nursing O
large O
litters O
. O

The O
sequences O
following O
the O
X O
. O
borealis O
oocyte O
and O
somatic O
5S I-GENE
genes I-GENE
are O
identical O
in O
12 O
of O
the O
first O
14 O
residues O
and O
contain O
two O
or O
more O
T O
clusters O
, O
as O
does O
the O
corresponding O
region O
of O
X I-GENE
. I-GENE
laevis I-GENE
oocyte I-GENE
5S I-GENE
DNA I-GENE
. O

This O
mechanism O
is O
not O
due O
to O
the O
observed O
grain O
boundary O
precipitates O
. O

This O
report O
has O
reviewed O
some O
of O
the O
reasons O
for O
treatment O
failures O
and O
has O
presented O
a O
philosophy O
for O
their O
management O
. O

Diagnosis O
and O
treatment O
planning O
in O
Class O
II O
, O
division O
2 O

Because O
of O
serious O
infections O
( O
fever O
larger O
than O
or O
equal O
to O
101 O
degrees O
F O
. O
granulocytes O
less O
than O
1 O
, O
000 O
/ O
mm O
, O
3 O
and O
hospitalization O
) O
and O
1 O
drug O
death O
in O
the O
first O
4 O
patients O
, O
oral O
calcium O
leucovorin O
, O
20 O
to O
30 O
mg O
/ O
m2 O
orally O
, O
was O
given O
2 O
days O
after O
methotrexate O
in O
subsequent O
treatment O
cycles O
. O

It O
seems O
that O
the O
way O
in O
which O
drugs O
modify O
a O
patient O
' O
s O
serum O
chemistry O
may O
be O
used O
to O
assess O
the O
efficacy O
with O
which O
they O
control O
the O
inflammatory O
process O
. O

Here O
the O
conventional O
tests O
clearly O
pointed O
to O
the O
presence O
of O
retrocochlear O
disease O
. O

The O
end O
- O
stage O
or O
involutional O
phase O
of O
proliferative O
diabetic O
retinopathy O
may O
result O
in O
